Ip receptor antagonists for the treatment of pathological uterine conditions

摘要

A method of combating a pathological condition of the uterus in a female individual, the method comprising administering to the individual at least one agent that is an antagonist of the IP receptor and/or a PGIS inhibitor. The pathological condition of the uterus is uterine carcinoma, menorrhagia, dysmenorrhoea or an endomenstrual myometrial pathological condition.